- Active ingredient
- cerebrolysin
- Strength
- 215.2mg/ml
- Form
- ampoule
- Manufacturer
- ever neuro pharma > b.p pharma
- Route
- injection
Uses
Used as a nootropic and neuroprotective agent in the management of Alzheimer's disease, vascular dementia, traumatic brain injury, and stroke recovery. May support cognitive function and neurological rehabilitation.
Do not use if
Contraindicated in known hypersensitivity to cerebrolysin or any excipient. Contraindicated in severe renal impairment and status epilepticus.
Side effects
Generally well tolerated. Reported side effects include dizziness, agitation, increased sweating, loss of appetite, and injection-site reactions. Rare cases of hypersensitivity reactions have been reported.
Warnings
Use with caution in patients with epilepsy as it may lower the seizure threshold. Contains active peptide fractions; monitor patients with known allergies carefully.
How it works
Cerebrolysin is a standardised mixture of low-molecular-weight neuropeptides and free amino acids derived from purified porcine brain proteins. It exerts neurotrophic effects similar to endogenous nerve growth factors, promoting neuronal survival, plasticity, and repair.
Storage
Store between 15–25°C, protected from light. Do not freeze. Keep in original packaging.